APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccines

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Selected research

Market Outlook & Growth Opportunities

Global Oral Vaccines Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchOral Vaccines Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccines Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

Read the full market overview

Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

This report provides an overview of the global Oral Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Vaccines Segment by Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Oral Vaccines Segment by Type

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Oral Vaccines Segment by Application

Public

Private

Oral Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Vaccines industry.

Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Vaccines Industry Trends Table 2. Oral Vaccines Industry Drivers Table 3. Oral Vaccines Industry Opportunities and Challenges Table 4. Oral Vaccines Industry Restraints Table 5. Global Oral Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Vaccines Revenue Share by Company (2021-2026) Table 7. Global Oral Vaccines Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Oral Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Oral Vaccines Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Oral Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Oral Vaccines Company, Product Type & Application Table 13. Global Oral Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rotavirus Vaccine Table 18. Significant Companies of Cholera Vaccine Table 19. Significant Companies of Oral Polio Vaccine Table 20. Global Oral Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 21. Global Oral Vaccines Sales Volume by Type (2021-2026) & (M Doses) Table 22. Global Oral Vaccines Sales Volume by Type (2027-2032) & (M Doses) Table 23. Global Oral Vaccines Sales Volume Share by Type (2021-2026) Table 24. Global Oral Vaccines Sales Volume Share by Type (2027-2032) Table 25. Global Oral Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oral Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Oral Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Oral Vaccines Sales Value Share by Type (2021-2026) Table 29. Global Oral Vaccines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Public Table 31. Significant Companies of Private Table 32. Global Oral Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 33. Global Oral Vaccines Sales Volume by Application (2021-2026) & (M Doses) Table 34. Global Oral Vaccines Sales Volume by Application (2027-2032) & (M Doses) Table 35. Global Oral Vaccines Sales Volume Share by Application (2021-2026) Table 36. Global Oral Vaccines Sales Volume Share by Application (2027-2032) Table 37. Global Oral Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Oral Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Oral Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Oral Vaccines Sales Value Share by Application (2021-2026) Table 41. Global Oral Vaccines Sales Value Share by Application (2027-2032) Table 42. Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 43. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses) Table 44. Global Oral Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Oral Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global Oral Vaccines Sales Market Share by Region (2027-2032) Table 47. Global Oral Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Oral Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Oral Vaccines Sales Value Share by Region (2021-2026) Table 50. Global Oral Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Oral Vaccines Sales Value Share by Region (2027-2032) Table 52. Global Oral Vaccines Market Average Price (USD/K Doses) by Region (2021-2026) Table 53. Global Oral Vaccines Market Average Price (USD/K Doses) by Region (2027-2032) Table 54. Global Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. Global Oral Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. Global Oral Vaccines Sales Market Share by Country (2021-2026) Table 58. Global Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 59. Global Oral Vaccines Sales Market Share by Country (2027-2032) Table 60. Global Oral Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Oral Vaccines Sales Value Market Share by Country (2021-2026) Table 62. Global Oral Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Oral Vaccines Sales Value Market Share by Country (2027-2032) Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 67. Merck Oral Vaccines Product Portfolio Table 68. Merck Recent Development Table 69. GSK Company Information Table 70. GSK Business Overview Table 71. GSK Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 72. GSK Oral Vaccines Product Portfolio Table 73. GSK Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 77. Sanofi Oral Vaccines Product Portfolio Table 78. Sanofi Recent Development Table 79. Lanzhou Institute Company Information Table 80. Lanzhou Institute Business Overview Table 81. Lanzhou Institute Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 82. Lanzhou Institute Oral Vaccines Product Portfolio Table 83. Lanzhou Institute Recent Development Table 84. Serum Institute Company Information Table 85. Serum Institute Business Overview Table 86. Serum Institute Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 87. Serum Institute Oral Vaccines Product Portfolio Table 88. Serum Institute Recent Development Table 89. Valneva Company Information Table 90. Valneva Business Overview Table 91. Valneva Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 92. Valneva Oral Vaccines Product Portfolio Table 93. Valneva Recent Development Table 94. Shanghai United Cell Company Information Table 95. Shanghai United Cell Business Overview Table 96. Shanghai United Cell Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 97. Shanghai United Cell Oral Vaccines Product Portfolio Table 98. Shanghai United Cell Recent Development Table 99. Bibcol Company Information Table 100. Bibcol Business Overview Table 101. Bibcol Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 102. Bibcol Oral Vaccines Product Portfolio Table 103. Bibcol Recent Development Table 104. PaxVax Company Information Table 105. PaxVax Business Overview Table 106. PaxVax Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 107. PaxVax Oral Vaccines Product Portfolio Table 108. PaxVax Recent Development Table 109. Vabiotech Company Information Table 110. Vabiotech Business Overview Table 111. Vabiotech Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 112. Vabiotech Oral Vaccines Product Portfolio Table 113. Vabiotech Recent Development Table 114. Tiantan Biological Company Information Table 115. Tiantan Biological Business Overview Table 116. Tiantan Biological Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 117. Tiantan Biological Oral Vaccines Product Portfolio Table 118. Tiantan Biological Recent Development Table 119. EuBiologics Company Information Table 120. EuBiologics Business Overview Table 121. EuBiologics Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 122. EuBiologics Oral Vaccines Product Portfolio Table 123. EuBiologics Recent Development Table 124. Panacea Biotec Ltd Company Information Table 125. Panacea Biotec Ltd Business Overview Table 126. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 127. Panacea Biotec Ltd Oral Vaccines Product Portfolio Table 128. Panacea Biotec Ltd Recent Development Table 129. Bio-Med Company Information Table 130. Bio-Med Business Overview Table 131. Bio-Med Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 132. Bio-Med Oral Vaccines Product Portfolio Table 133. Bio-Med Recent Development Table 134. Halfkin Bio-Pharmaceuticals Company Information Table 135. Halfkin Bio-Pharmaceuticals Business Overview Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 137. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio Table 138. Halfkin Bio-Pharmaceuticals Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Oral Vaccines Distributors List Table 142. Oral Vaccines Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Oral Vaccines Product Image Figure 2. Global Oral Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Oral Vaccines Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Oral Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rotavirus Vaccine Image Figure 10. Cholera Vaccine Image Figure 11. Oral Polio Vaccine Image Figure 12. Global Oral Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 13. Global Oral Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Oral Vaccines Sales Volume Share by Type (2021-2032) Figure 15. Global Oral Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Oral Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Oral Vaccines Sales Value Share by Type (2021-2032) Figure 18. Public Image Figure 19. Private Image Figure 20. Global Oral Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 21. Global Oral Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Oral Vaccines Sales Volume Share by Application (2021-2032) Figure 23. Global Oral Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Oral Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Oral Vaccines Sales Value Share by Application (2021-2032) Figure 26. Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 27. Global Oral Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Oral Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Oral Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Oral Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. North America Oral Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Oral Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Oral Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Oral Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Oral Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Oral Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. South America Oral Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Oral Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Oral Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Oral Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Oral Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Oral Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Oral Vaccines Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Oral Vaccines Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine
Applications
  • Public
  • Private
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Lanzhou Institute
  • Serum Institute
  • Valneva
  • Shanghai United Cell
  • Bibcol
  • PaxVax
  • Vabiotech
  • Tiantan Biological
  • EuBiologics
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Oral Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Vaccines Market Dynamics
  1. 2.1 Oral Vaccines Industry Trends
  2. 2.2 Oral Vaccines Industry Drivers
  3. 2.3 Oral Vaccines Industry Opportunities and Challenges
  4. 2.4 Oral Vaccines Industry Restraints
3 Oral Vaccines Market by Company
  1. 3.1 Global Oral Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Oral Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Oral Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Oral Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Oral Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Vaccines Company Product Type and Application
  8. 3.8 Global Oral Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Vaccines Market by Type
  1. 4.1 Oral Vaccines Type Introduction
  2. 4.1.1 Rotavirus Vaccine
  3. 4.1.2 Cholera Vaccine
  4. 4.1.3 Oral Polio Vaccine
  5. 4.2 Global Oral Vaccines Sales Volume by Type
  6. 4.2.1 Global Oral Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oral Vaccines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Oral Vaccines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Oral Vaccines Sales Value by Type
  10. 4.3.1 Global Oral Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oral Vaccines Sales Value by Type (2021-2032)
  12. 4.3.3 Global Oral Vaccines Sales Value Share by Type (2021-2032)
5 Oral Vaccines Market by Application
  1. 5.1 Oral Vaccines Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Vaccines Sales Volume by Application
  5. 5.2.1 Global Oral Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Oral Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Oral Vaccines Sales Value by Application
  9. 5.3.1 Global Oral Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global Oral Vaccines Sales Value Share by Application (2021-2032)
6 Oral Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Oral Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Oral Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Oral Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Vaccines Sales Value Share by Country, 2025 VS 2032
7 Oral Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Oral Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Oral Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK Oral Vaccines Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oral Vaccines Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Lanzhou Institute
  20. 8.4.1 Lanzhou Institute Company Information
  21. 8.4.2 Lanzhou Institute Business Overview
  22. 8.4.3 Lanzhou Institute Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
  24. 8.4.5 Lanzhou Institute Recent Developments
  25. 8.5 Serum Institute
  26. 8.5.1 Serum Institute Company Information
  27. 8.5.2 Serum Institute Business Overview
  28. 8.5.3 Serum Institute Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute Oral Vaccines Product Portfolio
  30. 8.5.5 Serum Institute Recent Developments
  31. 8.6 Valneva
  32. 8.6.1 Valneva Company Information
  33. 8.6.2 Valneva Business Overview
  34. 8.6.3 Valneva Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Valneva Oral Vaccines Product Portfolio
  36. 8.6.5 Valneva Recent Developments
  37. 8.7 Shanghai United Cell
  38. 8.7.1 Shanghai United Cell Company Information
  39. 8.7.2 Shanghai United Cell Business Overview
  40. 8.7.3 Shanghai United Cell Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
  42. 8.7.5 Shanghai United Cell Recent Developments
  43. 8.8 Bibcol
  44. 8.8.1 Bibcol Company Information
  45. 8.8.2 Bibcol Business Overview
  46. 8.8.3 Bibcol Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bibcol Oral Vaccines Product Portfolio
  48. 8.8.5 Bibcol Recent Developments
  49. 8.9 PaxVax
  50. 8.9.1 PaxVax Company Information
  51. 8.9.2 PaxVax Business Overview
  52. 8.9.3 PaxVax Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 PaxVax Oral Vaccines Product Portfolio
  54. 8.9.5 PaxVax Recent Developments
  55. 8.10 Vabiotech
  56. 8.10.1 Vabiotech Company Information
  57. 8.10.2 Vabiotech Business Overview
  58. 8.10.3 Vabiotech Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Vabiotech Oral Vaccines Product Portfolio
  60. 8.10.5 Vabiotech Recent Developments
  61. 8.11 Tiantan Biological
  62. 8.11.1 Tiantan Biological Company Information
  63. 8.11.2 Tiantan Biological Business Overview
  64. 8.11.3 Tiantan Biological Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
  66. 8.11.5 Tiantan Biological Recent Developments
  67. 8.12 EuBiologics
  68. 8.12.1 EuBiologics Company Information
  69. 8.12.2 EuBiologics Business Overview
  70. 8.12.3 EuBiologics Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 EuBiologics Oral Vaccines Product Portfolio
  72. 8.12.5 EuBiologics Recent Developments
  73. 8.13 Panacea Biotec Ltd
  74. 8.13.1 Panacea Biotec Ltd Company Information
  75. 8.13.2 Panacea Biotec Ltd Business Overview
  76. 8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
  78. 8.13.5 Panacea Biotec Ltd Recent Developments
  79. 8.14 Bio-Med
  80. 8.14.1 Bio-Med Company Information
  81. 8.14.2 Bio-Med Business Overview
  82. 8.14.3 Bio-Med Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Med Oral Vaccines Product Portfolio
  84. 8.14.5 Bio-Med Recent Developments
  85. 8.15 Halfkin Bio-Pharmaceuticals
  86. 8.15.1 Halfkin Bio-Pharmaceuticals Company Information
  87. 8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
  88. 8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
  90. 8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Vaccines Value Chain Analysis
  2. 9.1.1 Oral Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Vaccines Sales Mode & Process
  6. 9.2 Oral Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Vaccines Distributors
  9. 9.2.3 Oral Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst